DementiaSymptoms, Doctors, Treatments, Advances & More
Learn About Dementia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Brigham And Women's Hospital, Neurosciences Center
Reisa Sperling is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Sperling is rated as an Elite provider by MediFind in the treatment of Dementia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Alzheimer's Disease, Dementia, Memory Loss, Primary Amyloidosis, and Hormone Replacement Therapy (HRT).
UPMC Department Of Neurology
Tharick Pascoal, MD, Ph.D., is a neurologist and assistant professor of Neurology and Psychiatry at the University of Pittsburgh School of Medicine. Dr. Pascoal’s clinical and research interests include cognitive disorders of multiple etiologies, including Alzheimer’s disease and other dementias. He has published several research papers in peer-reviewed journals which can be found here. Dr. Pascoal is rated as an Elite provider by MediFind in the treatment of Dementia. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Movement Disorders, and Primary Amyloidosis. Dr. Pascoal is currently accepting new patients.
Emory Brain Health Center
Allan Levey is a Neurologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 42 years. Dr. Levey is rated as an Elite provider by MediFind in the treatment of Dementia. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Movement Disorders, and Parkinson's Disease. Dr. Levey is board certified in American Board Of Psychiatry And Neurology, 1990.
Summary: The goal of this international observational study is to evaluate long-term disease outcomes and treatment safety in people with Alzheimer's disease (PwAD), by collecting real-world data from routine clinical practice across global clinical centers. The InRAD Registry Observational Study has several aims: * To collect medical information for many years from a large group of people with Alzheimer's...
Background: About 5 million adults in the United States have age-related brain disorders. These include Alzheimer disease (AD), mild cognitive impairment (MCI), and other dementias. The number of people with these disorders will likely increase as the population ages and life span increases. Inflammation is thought to play a role in AD and MCI. Researchers want to know if an enzyme called PDE4B increases infl...